CVS - CVS Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 583.31B
Enterprise Value 3167.23B
Trailing P/E 17.55
Forward P/E 18.88
PEG Ratio (5 yr expected) 12.36
Price/Sales (ttm)0.37
Price/Book (mrq)1.36
Enterprise Value/Revenue 30.74
Enterprise Value/EBITDA 611.28

Trading Information

Stock Price History

Beta (3Y Monthly) 1.00
52-Week Change 3-18.18%
S&P500 52-Week Change 34.18%
52 Week High 382.15
52 Week Low 351.72
50-Day Moving Average 359.85
200-Day Moving Average 355.86

Share Statistics

Avg Vol (3 month) 38.17M
Avg Vol (10 day) 38.03M
Shares Outstanding 51.3B
Float 1.3B
% Held by Insiders 10.24%
% Held by Institutions 183.80%
Shares Short (Aug 15, 2019) 421.32M
Short Ratio (Aug 15, 2019) 42.58
Short % of Float (Aug 15, 2019) 41.65%
Short % of Shares Outstanding (Aug 15, 2019) 41.64%
Shares Short (prior month Jul 15, 2019) 421M

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 43.13%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 33.13%
5 Year Average Dividend Yield 42.22
Payout Ratio 456.34%
Dividend Date 3Aug 2, 2019
Ex-Dividend Date 4Jul 24, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 7, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 1.91%
Operating Margin (ttm)4.96%

Management Effectiveness

Return on Assets (ttm)3.98%
Return on Equity (ttm)8.90%

Income Statement

Revenue (ttm)226.05B
Revenue Per Share (ttm)190.76
Quarterly Revenue Growth (yoy)35.20%
Gross Profit (ttm)30.88B
EBITDA 14.83B
Net Income Avi to Common (ttm)4.32B
Diluted EPS (ttm)3.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.53B
Total Cash Per Share (mrq)6.55
Total Debt (mrq)91.92B
Total Debt/Equity (mrq)149.23
Current Ratio (mrq)0.95
Book Value Per Share (mrq)47.18

Cash Flow Statement

Operating Cash Flow (ttm)10.86B
Levered Free Cash Flow (ttm)13.55B